Literature DB >> 8494475

Adolescent blood pressure in a cohort study of sickle cell disease.

J Homi1, L Homi-Levee, S Gentles, P Thomas, G Serjeant.   

Abstract

BACKGROUND: Previous studies on low blood pressure in patients with homozygous sickle cell (SS) disease have sought new hypotheses on the mechanism of low blood pressure but have not analyzed the role of known determinants such as weight.
METHODS: Blood pressure has been measured by an automated oscillometric method in 220 patients with SS disease, 144 with sickle cell-hemoglobin C disease (both groups aged, 9.5 to 18.5 years) and 122 control subjects with a normal hemoglobin genotype (aged 16.0 to 18.5 years) participating in a cohort study from birth.
RESULTS: Significant age-related increases in systolic and mean arterial pressure occurred in sickle cell-hemoglobin C disease but not in SS disease. Further analyses were confined to a subgroup of 51 patients with SS, 41 patients with sickle cell-hemoglobin C, and 97 subjects with normal hemoglobin, aged 16.0 to 18.5 years in whom simultaneous measurements of height, weight, arm circumference, and hematologic test results were also available. Crude analyses showed significantly lower systolic, diastolic, and mean arterial pressure in SS disease compared with control subjects with normal hemoglobin, but further analysis showed the systolic difference to be confined to males and all differences disappeared after adjustment for weight. No differences occurred in sickle cell-hemoglobin C disease.
CONCLUSIONS: These results suggest that the lower blood pressure in SS disease is attributable to low weight and that no further mechanisms need be postulated.

Entities:  

Mesh:

Year:  1993        PMID: 8494475

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Masked hypertension is prevalent in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.

Authors:  Ibrahim F Shatat; Sherron M Jakson; Amanda E Blue; Mary A Johnson; John K Orak; Ram Kalpatthi
Journal:  Pediatr Nephrol       Date:  2012-08-11       Impact factor: 3.714

2.  Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.

Authors:  Abel Makubi; Bruno P Mmbando; Enrico M Novelli; Johnson Lwakatare; Deogratius Soka; Harvest Marik; Kemi Tibarazwa; Mariam Ngaeje; Charles R Newton; Mark T Gladwin; Julie Makani
Journal:  Br J Haematol       Date:  2016-09-21       Impact factor: 6.998

3.  Chronic kidney disease is common in sickle cell disease: a cross-sectional study in the Tema Metropolis, Ghana.

Authors:  Richard Kobina Dadzie Ephraim; Derick Nii Mensah Osakunor; Obed Cudjoe; Enos Amoako Oduro; Lyudmila Asante-Asamani; Juliana Mitchell; Hope Agbodzakey; Prince Adoba
Journal:  BMC Nephrol       Date:  2015-05-29       Impact factor: 2.388

4.  Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.

Authors:  Pallav Bhatnagar; Emily Barron-Casella; Christopher J Bean; Jacqueline N Milton; Clinton T Baldwin; Martin H Steinberg; Michael Debaun; James F Casella; Dan E Arking
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

5.  Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease.

Authors:  Enrico M Novelli; Mariana Hildesheim; Caterina Rosano; Rebecca Vanderpool; Marc Simon; Gregory J Kato; Mark T Gladwin
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

6.  Blood pressure in children with sickle cell disease is higher than in the general pediatric population.

Authors:  Juan C Kupferman; Janet E Rosenbaum; Marc B Lande; Stella Stabouli; Yongsheng Wang; Daniella Forman; Dimitrios I Zafeiriou; Steven G Pavlakis
Journal:  BMC Pediatr       Date:  2022-09-15       Impact factor: 2.567

7.  Renal function in children suffering from sickle cell disease: challenge of early detection in highly resource-scarce settings.

Authors:  Michel Ntetani Aloni; René Makwala Ngiyulu; Jean-Lambert Gini-Ehungu; Célestin Ndosimao Nsibu; Mathilde Bothale Ekila; François Bompeka Lepira; Nazaire Mangani Nseka
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.